USEUROPEAFRICAASIA 中文雙語Fran?ais
    China
    Home / China / Health

    Drug prices negotiated downward

    By Hou Liqiang | China Daily | Updated: 2017-07-20 07:10

    The prices of 36 expensive drugs - half of them for cancer treatment - are now covered by medical insurance, after the authorities negotiated substantial price reductions.

    The Ministry of Human Resources and Social Security negotiated with pharmaceutical manufacturers on 44 drugs and managed to cut prices of 36 of them to be acceptable for coverage by the medical insurance fund, Xu Yanjun, a fund management official at the ministry, said at a news conference on Wednesday.

    Compared with retail prices last year, prices of these drugs have decreased by 44 percent on average, he said. Five of the drugs are traditional Chinese medicines and 22 are imported Western medicines.

    Half the drugs, including 15 Western ones, are used to treat six types of cancer, including breast, lung and liver cancer. For example, the price of 440-milliliter trastuzumab, which is used to treat breast cancer, went down by 69 percent to 7,600 yuan ($1,125), said Yan Qinghui, the ministry's deputy director of medical insurance.

    He said the government chose the 44 drugs for negotiation after it found the medical fund couldn't afford them, even though they are greatly needed by the public due to their curative effects. They may be patented or produced exclusively by certain pharmaceutical companies.

    "We hoped we could make full use of the advantages of the fund's group purchasing to include more drugs in the medical insurance directory," Yan said.

    Prices of the drugs may be adjusted further when the contracts between the government and the manufacturers expire at the end of 2019, but they will also be subject to change if new medicines cause changes in exclusivity, he said.

    Xu said two independent teams comprising experts with clinical, pharmaceutical, economic and medical insurance expertise evaluated the medicines, along with the medical insurance fund's capacity, before prices were set.

    He added that the whole negotiation process, which took place on June 16, was videotaped for supervision checks.

    Chen Wen, deputy director of Fudan University's Institute of Hospital Management Research in Shanghai, said, "It's a great innovation to bring a negotiation mechanism to the revision of the medical insurance directory this year.

    "It's beyond doubt that price negotiations will play a bigger role in medical insurance."

    The ministry's negotiations for the 44 drugs laid a good foundation for the establishment of a more regulated and complete negotiation mechanism, he added.

    houliqiang@chinadaily.com.cn

    Editor's picks
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
     
    亚洲熟妇中文字幕五十中出| 久久精品aⅴ无码中文字字幕不卡 久久精品aⅴ无码中文字字幕重口 | 国产亚洲精品无码专区| 无码AV中文字幕久久专区| 国产免费黄色无码视频| 中文字幕在线播放| 欧洲人妻丰满av无码久久不卡 | 国产午夜精品无码| 亚洲中文字幕伊人久久无码| 最近中文字幕免费2019| 无码人妻精品一区二区三区久久 | 亚洲国产精品无码久久SM| 国产成人无码18禁午夜福利p| 亚洲日本中文字幕一区二区三区 | 亚洲AⅤ永久无码精品AA| 成人精品一区二区三区中文字幕 | 中文字幕亚洲情99在线| 国产亚洲3p无码一区二区| 亚洲精品无码久久千人斩| 久久精品?ⅴ无码中文字幕 | 日韩精品无码久久久久久| 久久久久av无码免费网| 97无码免费人妻超| 色多多国产中文字幕在线| 无码中文av有码中文a| 中文字幕无码av激情不卡久久| 狠狠精品干练久久久无码中文字幕 | 日韩精品无码一区二区三区| 西西午夜无码大胆啪啪国模| 伊人久久无码中文字幕| 中文 在线 日韩 亚洲 欧美| 无码人妻精品一区二区三18禁 | 乱人伦中文视频高清视频| 天堂资源8中文最新版| 国产在线精品无码二区| 无码人妻精品一区二区三区东京热| 亚洲av无码不卡| 精品无码一区二区三区爱欲九九 | 精品欧洲av无码一区二区14| 最近免费中文字幕大全免费| 亚洲av午夜国产精品无码中文字 |